Evidence map›Paper›PMID 32730998›Full record

ArticleThe Journal of infection2021

Mobile health technology combats COVID-19 in China.

Jieyu Wu, Xiaowei Xie, Le Yang, Xingyan Xu, Yingying Cai, Tinggui Wang, Xiaoxu Xie

Abstract readLetterComment
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Smartphone-Based Cancer and Obesity Prevention Education Program for Chinese Women (SCOPE): A Pilot RCT.International journal of environmental research and public health · 2023
    Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jieyu WuSchool of Public Health, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou 350122, China.
Xiaowei XieThe First Clinical Medical School, Shanxi Medical University, No. 98 Daxue Street, Taiyuan 030619, China.
Le YangSchool of Public Health, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou 350122, China.
Xingyan XuSchool of Public Health, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou 350122, China.
Yingying CaiSchool of Public Health, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou 350122, China.
Tinggui WangSchool of Public Health, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou 350122, China.
Xiaoxu XieSchool of Public Health, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou 350122, China. Electronic address: xiexiaoxu@aliyun.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

China empowers mobile health technologies to fight against COVID-19 pandemic. The success of mobile health here may be a useful reference for other parts of the world. We explore China's application of mobile health technologies to replenishing traditional public-health and social approaches for mitigating and suppressing COVID-19, and found that Internet hospitals alleviate the unavailability, inaccessibility, and inequity of health services during the outbreak; the fact-check and information-release platforms reduce the spread of misinformation; and the infection risk scoring systems facilitate restoring the order of production and life.

Indexed as

COVID-19TelemedicineBiomedical TechnologyChinaHospitalsHumansInternetPandemicsSARS-CoV-2

Identifiers

PMID32730998
PMCPMC7384407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.